{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:14:55Z","timestamp":1791904495150,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1046\/j.1469-0691.2003.00573.x","type":"journal-article","created":{"date-parts":[[2003,7,28]],"date-time":"2003-07-28T10:10:07Z","timestamp":1059387007000},"page":"590-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000\u20132001"],"prefix":"10.1016","volume":"9","author":[{"given":"M.E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Blosser-Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.A.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Thornsberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00573.x_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/38.suppl_A.117","article-title":"Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study","volume":"38","author":"Baquero","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","article-title":"Pneumococcal resistance to antibiotics","volume":"3","author":"Klugman","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.45.4.1037-1042.2001","article-title":"Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2 year longitudinal analysis","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239474","article-title":"In vitro activity of BAY 12-8039, a new 8-methoxyquinolone","volume":"42","author":"Dalhoff","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0924-8579(98)00020-X","article-title":"In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens","volume":"10","author":"Souli","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/AAC.41.1.101","article-title":"In vitro activity of BAY 12-8039, a new fluoroquinolone","volume":"41","author":"Woodcock","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0732-8893(00)00128-0","article-title":"Benchmarking the activity of moxifloxacin against recent clinical isolates of Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae: a European multi-center study","volume":"37","author":"Jones","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib9","series-title":"Methods for dilution antimicrobial tests for bacteria that grow aerobically, 5th edn. M7-A5","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib10","series-title":"Performance standards for antimicrobial susceptibility testing, Twelth Informational Supplement. M100-S12","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib11","series-title":"Performance standards for antimicrobial susceptibility testing, Eleventh Informational Supplement. M100-S11","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jac\/41.3.420","article-title":"Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland","volume":"41","author":"Goldsmith","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib15","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/AAC.44.9.2521-2524.2000","article-title":"Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States","volume":"44","author":"Sahm","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","article-title":"Mutation prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae","volume":"45","author":"Blondeau","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0732-8893(00)00110-3","article-title":"Fluoroquinolone-resistant Haemophilus influenzae. Frequency of occurrence and analysis of confirmed strains in the SENTRY Antimicrobial Surveillance Program (North and Latin America)","volume":"36","author":"Biedenbach","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib18","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/AAC.44.10.2645-2652.2000","article-title":"Benchmarking the in vitro activity of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States","volume":"44","author":"Jones","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/45.4.457","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997\u201398","volume":"45","author":"Sahm","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 3","key":"10.1046\/j.1469-0691.2003.00573.x_bib20","first-page":"18","article-title":"Trends in the activity of macrolide and \u03b2-lactam antibiotics and resistance development","volume":"9","author":"Schito GC, Manelli S, Pesce A, the Alexander Project","year":"1997","journal-title":"J Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/46.4.557","volume":"46","author":"Marco","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jac\/47.2.215","article-title":"Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study","volume":"47","author":"Oteo","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2003.00573.x_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1179\/joc.1999.11.Supplement-2.5","article-title":"Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens\u2014findings of the Alexander project 1992\u201396","volume":"11","author":"Felmingham","year":"1999","journal-title":"J Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14639471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14639471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:18:16Z","timestamp":1761117496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14639471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S1198743X14639471"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00573.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000\u20132001","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00573.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}